Panacea Innovation Ltd, 10% Owner, Director at Atara Biotherapeutics, Inc. (ATRA), bought 55,000 shares at $12.19 ($670K) on 2025-08-15, disclosed to the SEC on 2025-08-19.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.